1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Diabetes Care Devices In France 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, 2003-2017
11
3.3 Diabetes Care Devices Market, France, Revenue Mix ($m), 2010 12
3.4 Diabetes Care Devices Market, France, Category Contribution (%), 2010 13
3.5 Diabetes Care Devices, France, Category Volume (Units), 2003-2017 17
3.6 Diabetes Care Devices, France, Company share (2009-2010) 20
4 Glucose Monitoring In France 22
4.1 Glucose Monitoring, Market Segmentation 22
4.2 Glucose Monitoring Market, France, Revenue Mix ($m), 2010 23
4.3 Glucose Monitoring Market, France, Segment Contribution (%), 2010 24
4.4 Glucose Monitoring Overall Revenue (2003-2017) 25
4.4.1 Blood Glucose Meters Revenue (2003-2017) 29
4.5 Glucose Monitoring Overall Volume (2003-2017) 33
4.5.1 Blood Glucose Meters Volume (2003-2017) 37
4.6 Glucose Monitoring Average Price (2003-2017) 39
4.7 Glucose Monitoring Distribution Share (2009-2010) 40
4.8 Glucose Monitoring, France, Company share (2009-2010) 41
5 Insulin Delivery In France 42
5.1 Insulin Delivery, Market Segmentation 42
5.2 Insulin Delivery Market, France, Revenue Mix ($m), 2010 43
5.3 Insulin Delivery Market, France, Segment Contribution (%), 2010 44
5.4 Insulin Delivery Overall Revenue (2003-2017) 45
5.4.1 Insulin Pens Revenue (2003-2017) 49
5.4.2 Insulin Pumps Revenue (2003-2017) 53
5.5 Insulin Delivery Overall Volume (2003-2017) 55
5.5.1 Insulin Pens Volume (2003-2017) 59
5.5.2 Insulin Pumps Volume (2003-2017) 63
5.6 Insulin Delivery Average Price (2003-2017) 65
5.7 Insulin Delivery Distribution Share (2009-2010) 66
5.8 Insulin Delivery, France, Company share (2009-2010) 67
6 Overview of Key Companies in France Diabetes Care Devices Market 69
6.1 F. Hoffmann-La Roche Ltd. 69
6.1.1 Company Overview 69
6.1.2 Share in the France Diabetes Care Devices Market 69
6.2 Sanofi 70
6.2.1 Company Overview 70
6.2.2 Share in the France Diabetes Care Devices Market 70
6.3 Eli Lilly and Company 71
6.3.1 Company Overview 71
6.3.2 Share in the France Diabetes Care Devices Market 71
6.4 Novo Nordisk A/S 72
6.4.1 Company Overview 72
6.4.2 Share in the France Diabetes Care Devices Market 72
6.5 LifeScan, Inc. 73
6.5.1 Company Overview 73
6.5.2 Share in the France Diabetes Care Devices Market 73
6.6 Medtronic, Inc. 74
6.6.1 Company Overview 74
6.6.2 Share in the France Diabetes Care Devices Market 74
6.7 Bayer HealthCare AG 75
6.7.1 Company Overview 75
6.8 Abbott Laboratories 75
6.8.1 Company Overview 75
6.9 Ypsomed Holding AG 75
6.9.1 Company Overview 75
6.10 Animas Corporation 76
6.10.1 Company Overview 76
6.11 Becton, Dickinson and Company 76
6.11.1 Company Overview 76
6.12 ARKRAY, Inc. 76
6.12.1 Company Overview 76
6.13 NIPRO CORPORATION 77
6.13.1 Company Overview 77
7 Diabetes Care Devices Market Pipeline Products 78
8 Financial Deals Landscape 82
8.1 Partnerships 82
8.1.1 Trinity Biotech Enters Into Distribution Agreement with A. Menarini
Diagnostics 82
9 Recent Developments 83
9.1 Strategy and Business Planning 83
9.1.1 Nov 02, 2011: Sanofi To Shut Down R&D Site In Bridgewater, New Jersey 83
9.1.2 Jul 25, 2011: LEUKOCARE And Sanofi Pasteur Sign Cooperation Agreement For
Vaccine Stabilization 83
9.1.3 Jun 23, 2011: Roche Sets Up R&D Institute In France To Foster
Collaborative Translational Research 83
9.2 Government and Public Interest 84
9.2.1 Jan 27, 2011: Chinas Ministry Of Commerce Grants Clearance For Merger Of
BMP Sunstone And sanofi-aventis Subsidiary 84
10 Appendix 85
10.1 Definitions of Markets Covered in the Report 86
10.1.1 Diabetes Care Devices 86
10.2 Research Methodology 89
10.3 Secondary Research 89
10.4 Primary Research 90
10.5 Models 90
10.6 Forecasts 91
10.7 Expert Panels 91
10.8 GlobalData Consulting 91
10.9 Currency Conversion 92
10.10 Contact Us 92
10.11 Disclaimer 92
1.1 List of Tables
Table 1: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual,
2003-2017 11
Table 2: Diabetes Care Devices Market, France, Category Contribution (%), 2010
13
Table 3: Diabetes Care Devices, France, Cross-Segment Analysis, 2003-2017 14
Table 4: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual,
Historic, 2003-2010 15
Table 5: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual,
Forecast, 2010-2017 16
Table 6: Diabetes Care Devices, France, Category Volume (Units), 2003-2017 17
Table 7: Diabetes Care Devices, France, Category Volume (Units), Historic,
2003-2010 18
Table 8: Diabetes Care Devices, France, Category Volume (Units), Forecast,
2010-2017 19
Table 9: Diabetes Care Devices, France, Company share by Revenue ($m), USD
Actual, 2009-2010 21
Table 10: Glucose Monitoring Market, France, Segment Contribution (%), 2010 24
Table 11: Glucose Monitoring, France, Revenue ($m), USD Actual by Segment,
Historic, 2003-2010 26
Table 12: Glucose Monitoring, France, Revenue ($m), USD Actual by Segment,
Forecast, 2010-2017 28
Table 13: Blood Glucose Meters, France, Revenue ($m), USD Actual by Sub-Segment,
Historic, 2003-2010 30
Table 14: Blood Glucose Meters, France, Revenue ($m), USD Actual by Sub-Segment,
Forecast, 2010-2017 32
Table 15: Glucose Monitoring, France, Volume (Units) by Segment, Historic,
2003-2010 34
Table 16: Glucose Monitoring, France, Volume (Units) by Segment, Forecast,
2010-2017 36
Table 17: Blood Glucose Meters, France, Volume (Units) by Sub-Segment, Historic,
2003-2010 37
Table 18: Blood Glucose Meters, France, Volume (Units) by Sub-Segment, Forecast,
2010-2017 38
Table 19: Glucose Monitoring, France, Average Price ($), Historic, 2003-2010 39
Table 20: Glucose Monitoring, France, Average Price ($), Forecast, 2010-2017 39
Table 21: Glucose Monitoring, France, Distribution Share by Revenue ($m), USD
Actual, 2009-2010 40
Table 22: Glucose Monitoring, France, Company share by Revenue ($m), USD Actual
2009-2010 41
Table 23: Insulin Delivery Market, France, Segment Contribution (%), 2010 44
Table 24: Insulin Delivery, France, Revenue ($m), USD Actual by Segment,
Historic, 2003-2010 46
Table 25: Insulin Delivery, France, Revenue ($m), USD Actual by Segment,
Forecast, 2010-2017 48
Table 26: Insulin Pens, France, Revenue ($m), USD Actual by Sub-Segment,
Historic, 2003-2010 50
Table 27: Insulin Pens, France, Revenue ($m), USD Actual by Sub-Segment,
Forecast, 2010-2017 52
Table 28: Insulin Pumps (Traditional Insulin Pumps), France, Revenue ($m), USD
Actual, Historic, 2003-2010 53
Table 29: Insulin Pumps, France, Revenue ($m), USD Actual by Sub-Segment,
Forecast, 2010-2017 54
Table 30: Insulin Delivery, France, Volume (Units) by Segment, Historic,
2003-2010 56
Table 31: Insulin Delivery, France, Volume (Units) by Segment, Forecast,
2010-2017 58
Table 32: Insulin Pens, France, Volume (Units) by Sub-Segment, Historic,
2003-2010 60
Table 33: Insulin Pens, France, Volume (Units) by Sub-Segment, Forecast,
2010-2017 62
Table 34: Insulin Pumps (Traditional Insulin Pumps), France, Volume (Units),
Historic, 2003-2010 63
Table 35: Insulin Pumps, France, Volume (Units) by Sub-Segment, Forecast,
2010-2017 64
Table 36: Insulin Delivery, France, Average Price ($), Historic, 2003-2010 65
Table 37: Insulin Delivery, France, Average Price ($), Forecast, 2010-2017 65
Table 38: Insulin Delivery, France, Distribution Share by Revenue ($m), USD
Actual, 2009-2010 66
Table 39: Insulin Delivery, France, Company share by Revenue ($m), USD Actual
2009-2010 68
Table 40: Diabetes Care Devices Market Pipeline Products 78
Table 41: Trinity Biotech Enters Into Distribution Agreement With A. Menarini
Diagnostics 82
Table 42: USD to Local Currency, France, Average Actual Rate 2003-2010 92
1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation 10
Figure 2: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual,
2003-2017 11
Figure 3: Diabetes Care Devices Market, France, Revenue Mix ($m), 2010 12
Figure 4: Diabetes Care Devices Market, France, Category Contribution (%), 2010
13
Figure 5: Diabetes Care Devices, France, Cross-Segment Analysis, 2003-2017 14
Figure 6: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual,
Historic, 2003-2010 15
Figure 7: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual,
Forecast, 2010-2017 16
Figure 8: Diabetes Care Devices, France, Category Volume (Units), 2003-2017 17
Figure 9: Diabetes Care Devices, France, Category Volume (Units), Historic,
2003-2010 18
Figure 10: Diabetes Care Devices, France, Category Volume (Units), Forecast,
2010-2017 19
Figure 11: Diabetes Care Devices, France, Company share (%), 2010 20
Figure 12: Glucose Monitoring, Market Segmentation 22
Figure 13: Glucose Monitoring Market, France, Revenue Mix ($m), 2010 23
Figure 14: Glucose Monitoring Market, France, Segment Contribution (%), 2010 24
Figure 15: Glucose Monitoring, France, Revenue ($m), USD Actual by Segment,
Historic, 2003-2010 25
Figure 16: Glucose Monitoring, France, Revenue ($m), USD Actual by Segment,
Forecast, 2010-2017 27
Figure 17: Blood Glucose Meters, France, Revenue ($m), USD Actual by
Sub-Segment, Historic, 2003-2010 29
Figure 18: Blood Glucose Meters, France, Revenue ($m), USD Actual by
Sub-Segment, Forecast, 2010-2017 31
Figure 19: Glucose Monitoring, France, Volume (Units) by Segment, Historic,
2003-2010 33
Figure 20: Glucose Monitoring, France, Volume (Units) by Segment, Forecast,
2010-2017 35
Figure 21: Blood Glucose Meters, France, Volume (Units) by Sub-Segment,
Historic, 2003-2010 37
Figure 22: Blood Glucose Meters, France, Volume (Units) by Sub-Segment,
Forecast, 2010-2017 38
Figure 23: Glucose Monitoring, France, Company share (%), 2010 41
Figure 24: Insulin Delivery, Market Segmentation 42
Figure 25: Insulin Delivery Market, France, Revenue Mix ($m), 2010 43
Figure 26: Insulin Delivery Market, France, Segment Contribution (%), 2010 44
Figure 27: Insulin Delivery, France, Revenue ($m), USD Actual by Segment,
Historic, 2003-2010 45
Figure 28: Insulin Delivery, France, Revenue ($m), USD Actual by Segment,
Forecast, 2010-2017 47
Figure 29: Insulin Pens, France, Revenue ($m), USD Actual by Sub-Segment,
Historic, 2003-2010 49
Figure 30: Insulin Pens, France, Revenue ($m), USD Actual by Sub-Segment,
Forecast, 2010-2017 51
Figure 31: Insulin Pumps (Traditional Insulin Pumps), France, Revenue ($m), USD
Actual, Historic, 2003-2010 53
Figure 32: Insulin Pumps, France, Revenue ($m), USD Actual by Sub-Segment,
Forecast, 2010-2017 54
Figure 33: Insulin Delivery, France, Volume (Units) by Segment, Historic,
2003-2010 55
Figure 34: Insulin Delivery, France, Volume (Units) by Segment, Forecast,
2010-2017 57
Figure 35: Insulin Pens, France, Volume (Units) by Sub-Segment, Historic,
2003-2010 59
Figure 36: Insulin Pens, France, Volume (Units) by Sub-Segment, Forecast,
2010-2017 61
Figure 37: Insulin Pumps (Traditional Insulin Pumps), France, Volume (Units),
Historic, 2003-2010 63
Figure 38: Insulin Pumps, France, Volume (Units) by Sub-Segment, Forecast,
2010-2017 64
Figure 39: Insulin Delivery, France, Company share (%), 2010 67
Figure 40: F. Hoffmann-La Roche Ltd., Company Share (%),France Diabetes Care
Devices Market, 2010 69
Figure 41: Sanofi, Company Share (%),France Diabetes Care Devices Market, 2010
70
Figure 42: Eli Lilly and Company, Company Share (%),France Diabetes Care Devices
Market, 2010 71
Figure 43: Novo Nordisk A/S, Company Share (%),France Diabetes Care Devices
Market, 2010 72
Figure 44: LifeScan, Inc., Company Share (%),France Diabetes Care Devices
Market, 2010 73
Figure 45: Medtronic, Inc., Company Share (%),France Diabetes Care Devices
Market, 2010 74
Companies Mentioned
F. Hoffmann-La Roche Ltd.
Sanofi
Eli Lilly and Company
Novo Nordisk A/S
LifeScan, Inc.
Medtronic, Inc.
Bayer HealthCare AG
Abbott Laboratories
Ypsomed Holding AG
Animas Corporation
Becton, Dickinson and Company
ARKRAY, Inc.
NIPRO CORPORATION |
